All News

News

T-cell immunity test against SARS-CoV2 by Avidin

Avidin has developed a novel blood based diagnostic test that measures acquired T-cell immunity against the SARS-CoV2 coronavirus, following infection or immunization. Avidin is the first private company to offer such a test in Hungary.

News

Avidin donates to children

Avidin’s enthusiastic team has participated in Hungarian Shoe Box Campaign, a child-assisting program, under which Christmas presents are donated to children in need.

News

New technological platform with national support

The aim of the project was the acquisition of the Advia Centaur® XPT immunochemical automate system manufactured by Siemens, followed by the adaptation of the test assays provided by the instrument.

News

Differentiation of Influenza and COVID-19

Avidin can simultaneously check for Covid-19 and Influenza infection from the same specimen by using its multi-diagnostic PCR solution with high specificity and sensitivity.

News

Ultrafast PCR test for COVID-19

Avidin, led by Dr. Liliana Fehér, has developed its own one-step RT-PCR kit, the Cov2QuantTM SARS-Cov-2 Quantification kit (cat: CQ-100), designed to detect the novel corona virus, SARS-Cov-2, quantitatively by using reverse trascription reaction and quantitative real-time polymerase chain reaction.

News

New test reagent series for COVID-19

Avidin has expanded the company’s portfolio with a specialized clinical molecular diagnostics department focused on the detection and monitoring of infectious diseases.

News

Avidin combats Covid-19 pandemic

Avidin set up viral diagnostics lab and developed own reagents and method to combat Covid-19 reported by HVG 05/28/2020 Avidin, reported by HVG (Weekly World